Compare $ACXP vs $APUS | Chartloom

Compare

$ACXP vs $APUS

Acurx Pharmaceuticals Inc · Apimeds Pharmaceuticals US Inc

ACXP

Acurx Pharmaceuticals Inc

APUS

Apimeds Pharmaceuticals US Inc

Compare $ACXP vs $APUS

Comparing Acurx Pharmaceuticals Inc and Apimeds Pharmaceuticals US Inc

ACXPAcurx Pharmaceuticals Inc

APUSApimeds Pharmaceuticals US Inc

ACXPAcurx Pharmaceuticals Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-54.0%

52W performance

-84.3%

FCF yield

-113.2%

APUSApimeds Pharmaceuticals US Inc

Market cap

$8M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-69.8%

52W performance

-75.9%

FCF yield

-70.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACXP

APUS

Detailed metrics comparison

ACXP

Acurx Pharmaceuticals Inc

APUS

Apimeds Pharmaceuticals US Inc

Market Cap

ACXP$5M

APUS$8M

Enterprise Value

ACXP$-5M

APUS$22M

Price

ACXP$1.27

APUS$5.02

P/E Ratio

ACXPN/A

APUSN/A

P/S Ratio

ACXP0.00x

APUS0.00x

EV/Sales

ACXP0.00x

APUS0.00x

EV/EBITDA

ACXP0.00x

APUS0.00x

P/B Ratio

ACXP0.87x

APUS0.05x

P/FCF Ratio

ACXPN/A

APUSN/A

EV/FCF

ACXP0.84x

APUS-4.06x

PEG Ratio

ACXPN/A

APUSN/A

Forward P/E (NTM)

ACXPN/A

APUSN/A

Forward P/S (NTM)

ACXPN/A

APUSN/A

Revenue (TTM)

ACXP$0

APUS$0

Revenue Growth (YoY)

ACXPN/A

APUSN/A

Forward Rev Growth

ACXP40.7%

APUS0.0%

Gross Margin (TTM)

ACXP0.0%

APUS0.0%

Operating Margin (TTM)

ACXP0.0%

APUS0.0%

EBITDA Margin (TTM)

ACXP0.0%

APUS0.0%

Net Margin (TTM)

ACXP0.0%

APUS0.0%

FCF Margin (TTM)

ACXPN/A

APUSN/A

Net Income (TTM)

ACXP$-8M

APUS$-58M

FCF (TTM)

ACXP$-6M

APUS$-5M

EPS (TTM)

ACXP-$1.76

APUS-$33.95

ROE (TTM)

ACXP-12474.0%

APUS-5898.0%

ROA (TTM)

ACXP-8749.0%

APUS-5261.0%

ROIC (TTM)

ACXP-12474.0%

APUS-5458.0%

Cash

ACXP$11M

APUS$278K

Debt

ACXP$0

APUS$14M

Net Cash/Debt

ACXP$11M

APUS$-14M

Current Ratio (TTM)

ACXP3.88x

APUS0.51x

Quick Ratio (TTM)

ACXP3.80x

APUS0.40x

Debt/Equity (TTM)

ACXP0.00x

APUS0.14x

Debt/Assets (TTM)

ACXP0.0%

APUS0.0%

Interest Coverage (TTM)

ACXPN/A

APUSN/A

Net Debt/EBITDA (TTM)

ACXP0.00x

APUS0.00x

Beta

ACXP-2.14

APUS2.60

52W Performance

ACXP-84.3%

APUS-75.9%

YTD Performance

ACXP-54.0%

APUS-69.8%

% from 52W High

ACXP-84.4%

APUS-91.6%

% from 52W Low

ACXP3.3%

APUS232.5%

Asset Turnover (TTM)

ACXP0.00x

APUS0.00x

FCF Yield (TTM)

ACXP-113.2%

APUS-70.6%

Earnings Yield (TTM)

ACXP-137.5%

APUS-767.4%

Dividend Yield (TTM)

ACXPN/A

APUSN/A

Rule of 40

ACXP0.0

APUS0.0

EV/GP/RG

ACXPN/A

APUSN/A

Ticker research

View ACXP research View APUS research

Metric	ACXP Acurx Pharmaceuticals Inc	APUS Apimeds Pharmaceuticals US Inc
Market & Valuation
Market Cap	$5M	$8M
Enterprise Value	$-5M	$22M
Price	$1.27	$5.02
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.87x	0.05x
P/FCF Ratio	N/A	N/A
EV/FCF	0.84x	-4.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	40.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-8M	$-58M
FCF (TTM)	$-6M	$-5M
EPS (TTM)	-$1.76	-$33.95
ROE (TTM)	-12474.0%	-5898.0%
ROA (TTM)	-8749.0%	-5261.0%
ROIC (TTM)	-12474.0%	-5458.0%
Financial Health
Cash	$11M	$278K
Debt	$0	$14M
Net Cash/Debt	$11M	$-14M
Current Ratio (TTM)	3.88x	0.51x
Quick Ratio (TTM)	3.80x	0.40x
Debt/Equity (TTM)	0.00x	0.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.14	2.60
52W Performance	-84.3%	-75.9%
YTD Performance	-54.0%	-69.8%
% from 52W High	-84.4%	-91.6%
% from 52W Low	3.3%	232.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-113.2%	-70.6%
Earnings Yield (TTM)	-137.5%	-767.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACXP research	View APUS research

Valuation

P/S Ratio

ACXP

0.00x

APUS

0.00x

EV/FCF

APUS

-4.06x

ACXP

0.84x

Growth & revenue

Forward Revenue Growth

ACXP

40.7%

APUS

0.0%

Profitability & performance

Gross Margin

ACXP

0.0%

APUS

0.0%

ROE

APUS

-5898.0%

ACXP

-12474.0%

FCF Yield %

APUS

-70.6%

ACXP

-113.2%

52-Week Performance

APUS

-75.9%

ACXP

-84.3%

Detailed metrics comparison

ACXP

Acurx Pharmaceuticals Inc

APUS

Apimeds Pharmaceuticals US Inc

Market Cap

ACXP$5M

APUS$8M

Enterprise Value

ACXP$-5M

APUS$22M

Price

ACXP$1.27

APUS$5.02

P/E Ratio

ACXPN/A

APUSN/A

P/S Ratio

ACXP0.00x

APUS0.00x

EV/Sales

ACXP0.00x

APUS0.00x

EV/EBITDA

ACXP0.00x

APUS0.00x

P/B Ratio

ACXP0.87x

APUS0.05x

P/FCF Ratio

ACXPN/A

APUSN/A

EV/FCF

ACXP0.84x

APUS-4.06x

PEG Ratio

ACXPN/A

APUSN/A

Forward P/E (NTM)

ACXPN/A

APUSN/A

Forward P/S (NTM)

ACXPN/A

APUSN/A

Revenue (TTM)

ACXP$0

APUS$0

Revenue Growth (YoY)

ACXPN/A

APUSN/A

Forward Rev Growth

ACXP40.7%

APUS0.0%

Gross Margin (TTM)

ACXP0.0%

APUS0.0%

Operating Margin (TTM)

ACXP0.0%

APUS0.0%

EBITDA Margin (TTM)

ACXP0.0%

APUS0.0%

Net Margin (TTM)

ACXP0.0%

APUS0.0%

FCF Margin (TTM)

ACXPN/A

APUSN/A

Net Income (TTM)

ACXP$-8M

APUS$-58M

FCF (TTM)

ACXP$-6M

APUS$-5M

EPS (TTM)

ACXP-$1.76

APUS-$33.95

ROE (TTM)

ACXP-12474.0%

APUS-5898.0%

ROA (TTM)

ACXP-8749.0%

APUS-5261.0%

ROIC (TTM)

ACXP-12474.0%

APUS-5458.0%

Cash

ACXP$11M

APUS$278K

Debt

ACXP$0

APUS$14M

Net Cash/Debt

ACXP$11M

APUS$-14M

Current Ratio (TTM)

ACXP3.88x

APUS0.51x

Quick Ratio (TTM)

ACXP3.80x

APUS0.40x

Debt/Equity (TTM)

ACXP0.00x

APUS0.14x

Debt/Assets (TTM)

ACXP0.0%

APUS0.0%

Interest Coverage (TTM)

ACXPN/A

APUSN/A

Net Debt/EBITDA (TTM)

ACXP0.00x

APUS0.00x

Beta

ACXP-2.14

APUS2.60

52W Performance

ACXP-84.3%

APUS-75.9%

YTD Performance

ACXP-54.0%

APUS-69.8%

% from 52W High

ACXP-84.4%

APUS-91.6%

% from 52W Low

ACXP3.3%

APUS232.5%

Asset Turnover (TTM)

ACXP0.00x

APUS0.00x

FCF Yield (TTM)

ACXP-113.2%

APUS-70.6%

Earnings Yield (TTM)

ACXP-137.5%

APUS-767.4%

Dividend Yield (TTM)

ACXPN/A

APUSN/A

Rule of 40

ACXP0.0

APUS0.0

EV/GP/RG

ACXPN/A

APUSN/A

Ticker research

View ACXP research View APUS research

Metric	ACXP Acurx Pharmaceuticals Inc	APUS Apimeds Pharmaceuticals US Inc
Market & Valuation
Market Cap	$5M	$8M
Enterprise Value	$-5M	$22M
Price	$1.27	$5.02
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.87x	0.05x
P/FCF Ratio	N/A	N/A
EV/FCF	0.84x	-4.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	40.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-8M	$-58M
FCF (TTM)	$-6M	$-5M
EPS (TTM)	-$1.76	-$33.95
ROE (TTM)	-12474.0%	-5898.0%
ROA (TTM)	-8749.0%	-5261.0%
ROIC (TTM)	-12474.0%	-5458.0%
Financial Health
Cash	$11M	$278K
Debt	$0	$14M
Net Cash/Debt	$11M	$-14M
Current Ratio (TTM)	3.88x	0.51x
Quick Ratio (TTM)	3.80x	0.40x
Debt/Equity (TTM)	0.00x	0.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.14	2.60
52W Performance	-84.3%	-75.9%
YTD Performance	-54.0%	-69.8%
% from 52W High	-84.4%	-91.6%
% from 52W Low	3.3%	232.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-113.2%	-70.6%
Earnings Yield (TTM)	-137.5%	-767.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACXP research	View APUS research